Eton Pharmaceuticals Inc expected to post earnings of 11 cents a share - Earnings Preview

Eton Pharmaceuticals

11/08/2026 21:34

Eton Pharmaceuticals Inc ETON.OQ ETON.O is expected to  show a rise in quarterly revenue when it reports  results on August 13 for the period ending June 30 2026
The Deer Park Illinois-based  company is expected to report a 43.3% increase in revenue to $27.119 million from $18.93 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Eton Pharmaceuticals Inc is for earnings of 11 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Eton Pharmaceuticals Inc is $61.00, about 39.7% above its last closing price of $43.67
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
0.07
0.09
0.05
Missed
-44.4
Dec. 31 2026
0.08
0.09
0.06
Missed
-33.3
Sep. 30 2025
0.08
0.09
-0.07
Missed
-177.8​
Jun. 30 2025
-0.01
-0.04
-0.10
Missed
-172.7
​​Mar. 31 2025
0.06
0.05
0.07
Beat
31.3
Dec. 31 2024
-0.01
0.00
-0.02
Missed
-500.6​
Sep. 30 2024
-0.01
-0.01
0.03
Beat
400
Jun. 30 2024
-0.07
-0.07
-0.12
Missed
-71.4
This summary was machine generated August 11 at 20:34 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)